FDA greenlights targeted therapy for lung cancer mutation
The Food and Drug Administration has approved the first drug for a specific mutation causing lung cancer in adult patients who have undergone at least one systemic treatment, such as chemotherapy.
via FOX NEWS https://ift.tt/3pa02GC
No comments:
Post a Comment
Thanks for your comment reply within 24 hours